475 Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockadeNamrata S. Patil, David S. Shames, Xiangnan Guan et al.|Regular and Young Investigator Award Abstracts|2022Cited by 3
Abstract 4055: Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in non-small cell lung cancer patients responding to atezolizumab treatmentMahesh Yadav, Evan W. Newell, Michael Fehlings et al.|Immunology|2019Cited by 0
Abstract 5712: Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockadeNamrata S. Patil, David S. Shames, Shyam Srivats et al.|Cancer Research|2023Cited by 0